-
1
-
-
80053581281
-
Blood sphingolipids in homeostasis and pathobiology
-
Hammad, S. M. 2011. Blood sphingolipids in homeostasis and pathobiology. Adv. Exp. Med. Biol. 721: 57-66.
-
(2011)
Adv. Exp. Med. Biol
, vol.721
, pp. 57-66
-
-
Hammad, S.M.1
-
2
-
-
77957866552
-
The protein cargo of HDL: Implications for vascular wall biology and therapeutics
-
Heinecke, J. W. 2010. The protein cargo of HDL: implications for vascular wall biology and therapeutics. J. Clin. Lipidol. 4: 371-375.
-
(2010)
J. Clin. Lipidol
, vol.4
, pp. 371-375
-
-
Heinecke, J.W.1
-
3
-
-
0032930315
-
High density lipoprotein receptors, binding proteins, and ligands
-
Fidge, N. H. 1999. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40: 187-201.
-
(1999)
J. Lipid Res
, vol.40
, pp. 187-201
-
-
Fidge, N.H.1
-
4
-
-
0024449985
-
High-density lipoprotein - The clinical implications of recent studies
-
Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
-
(1989)
N. Engl. J. Med
, vol.321
, pp. 1311-1316
-
-
Gordon, D.J.1
Rifkind, B.M.2
-
5
-
-
34748887666
-
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
-
Barter, P., A. M. Gotto, J. C. LaRosa, J. Maroni, M. Szarek, S. M. Grundy, J. J. Kastelein, V. Bittner, and J. C. Fruchart. 2007. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 357: 1301-1310.
-
(2007)
N. Engl. J. Med
, vol.357
, pp. 1301-1310
-
-
Barter, P.1
Gotto, A.M.2
Larosa, J.C.3
Maroni, J.4
Szarek, M.5
Grundy, S.M.6
Kastelein, J.J.7
Bittner, V.8
Fruchart, J.C.9
-
6
-
-
67649367650
-
Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study
-
Ridker, P. M., G. Pare, A. N. Parker, R. Y. Zee, J. P. Miletich, and D. I. Chasman. 2009. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study. Circ. Cardiovasc. Genet. 2: 26-33.
-
(2009)
Circ. Cardiovasc. Genet
, vol.2
, pp. 26-33
-
-
Ridker, P.M.1
Pare, G.2
Parker, A.N.3
Zee, R.Y.4
Miletich, J.P.5
Chasman, D.I.6
-
7
-
-
84864845456
-
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
-
Voight, B. F., G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Holm, E. L. Ding, T. Johnson, et al. 2012. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 380: 572-580.
-
(2012)
Lancet
, vol.380
, pp. 572-580
-
-
Voight, B.F.1
Peloso, G.M.2
Orho-Melander, M.3
Frikke-Schmidt, R.4
Barbalic, M.5
Jensen, M.K.6
Hindy, G.7
Holm, H.8
Ding, E.L.9
Johnson, T.10
-
8
-
-
0035969564
-
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
-
Brown, B. G., X. Q. Zhao, A. Chait, L. D. Fisher, M. C. Cheung, J. S. Morse, A. A. Dowdy, E. K. Marino, E. L. Bolson, P. Alaupovic, et al. 2001. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345: 1583-1592.
-
(2001)
N. Engl. J. Med
, vol.345
, pp. 1583-1592
-
-
Brown, B.G.1
Zhao, X.Q.2
Chait, A.3
Fisher, L.D.4
Cheung, M.C.5
Morse, J.S.6
Dowdy, A.A.7
Marino, E.K.8
Bolson, E.L.9
Alaupovic, P.10
-
9
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
-
Rubins, H. B., S. J. Robins, D. Collins, C. L. Fye, J. W. Anderson, M. B. Elam, F. H. Faas, E. Linares, E. J. Schaefer, G. Schectman, et al. 1999. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341: 410-418.
-
(1999)
N. Engl. J. Med
, vol.341
, pp. 410-418
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Fye, C.L.4
Anderson, J.W.5
Elam, M.B.6
Faas, F.H.7
Linares, E.8
Schaefer, E.J.9
Schectman, G.10
-
10
-
-
0034700643
-
High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial
-
Boden, W. E. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86: 19L-22L.
-
(2000)
Am. J. Cardiol
, vol.86
-
-
Boden, W.E.1
-
11
-
-
84855171302
-
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
-
Boden, W. E., J. L. Probstfield, T. Anderson, B. R. Chaitman, P. Svignes-Nickens, K. Koprowicz, R. McBride, K. Teo, and W. Weintraub. 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365: 2255-2267.
-
(2011)
N. Engl. J. Med
, vol.365
, pp. 2255-2267
-
-
Boden, W.E.1
Probstfield, J.L.2
Anderson, T.3
Chaitman, B.R.4
Svignes-Nickens, P.5
Koprowicz, K.6
McBride, R.7
Teo, K.8
Weintraub, W.9
-
12
-
-
0032881850
-
Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI
-
Krieger, M. 1999. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68: 523-558.
-
(1999)
Annu. Rev. Biochem
, vol.68
, pp. 523-558
-
-
Krieger, M.1
-
13
-
-
2642521483
-
Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids
-
Connelly, M. A., and D. L. Williams. 2004. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipidol. 15: 287-295.
-
(2004)
Curr. Opin. Lipidol
, vol.15
, pp. 287-295
-
-
Connelly, M.A.1
Williams, D.L.2
-
14
-
-
0037155049
-
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice
-
Braun, A., B. L. Trigatti, M. J. Post, K. Sato, M. Simons, J. M. Edelberg, R. D. Rosenberg, M. Schrenzel, and M. Kriege. 2002. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90: 270-276.
-
(2002)
Circ. Res
, vol.90
, pp. 270-276
-
-
Braun, A.1
Trigatti, B.L.2
Post, M.J.3
Sato, K.4
Simons, M.5
Edelberg, J.M.6
Rosenberg, R.D.7
Schrenzel, M.8
Kriege, M.9
-
15
-
-
0035856550
-
Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content
-
Rong, J. X., J. Li, E. D. Reis, R. P. Choudhury, H. M. Dansky, V. I. Elmalem, J. T. Fallon, J. L. Breslow, and E. A. Fisher. 2001. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 104: 2447-2452.
-
(2001)
Circulation
, vol.104
, pp. 2447-2452
-
-
Rong, J.X.1
Li, J.2
Reis, E.D.3
Choudhury, R.P.4
Dansky, H.M.5
Elmalem, V.I.6
Fallon, J.T.7
Breslow, J.L.8
Fisher, E.A.9
-
16
-
-
0027994776
-
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits
-
Ameli, S., A. Hultgardh-Nilsson, B. Cercek, P. K. Shah, J. S. Forrester, H. Ageland, and J. Nilsson. 1994. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation. 90: 1935-1941.
-
(1994)
Circulation
, vol.90
, pp. 1935-1941
-
-
Ameli, S.1
Hultgardh-Nilsson, A.2
Cercek, B.3
Shah, P.K.4
Forrester, J.S.5
Ageland, H.6
Nilsson, J.7
-
17
-
-
0031471857
-
Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice
-
De Geest, B., Z. Zhao, D. Collen, and P. Holvoet. 1997. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. Circulation. 96: 4349-4356.
-
(1997)
Circulation
, vol.96
, pp. 4349-4356
-
-
De Geest, B.1
Zhao, Z.2
Collen, D.3
Holvoet, P.4
-
18
-
-
38849114338
-
Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins
-
Tall, A. R. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263: 256-273.
-
(2008)
J. Intern. Med
, vol.263
, pp. 256-273
-
-
Tall, A.R.1
-
19
-
-
84859760161
-
Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport
-
Rosenson, R. S., H. B. Brewer, Jr., W. S. Davidson, Z. A. Fayad, V. Fuster, J. Goldstein, M. Hellerstein, X. C. Jiang, M. C. Phillips, D. J. Rader, et al. 2012. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 125: 1905-1919.
-
(2012)
Circulation
, vol.125
, pp. 1905-1919
-
-
Rosenson, R.S.1
Brewer Jr., H.B.2
Davidson, W.S.3
Fayad, Z.A.4
Fuster, V.5
Goldstein, J.6
Hellerstein, M.7
Jiang, X.C.8
Phillips, M.C.9
Rader, D.J.10
-
20
-
-
84866887473
-
Novel biological functions of high-density lipoprotein cholesterol
-
Mineo, C., and P. W. Shaul. 2012. Novel biological functions of high-density lipoprotein cholesterol. Circ. Res. 111: 1079-1090.
-
(2012)
Circ. Res
, vol.111
, pp. 1079-1090
-
-
Mineo, C.1
Shaul, P.W.2
-
21
-
-
0031458496
-
HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2)
-
Vinals, M., J. Martinez-Gonzalez, J. J. Badimon, and L. Badimon. 1997. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler. Thromb. Vasc. Biol. 17: 3481-3488.
-
(1997)
Arterioscler. Thromb. Vasc. Biol
, vol.17
, pp. 3481-3488
-
-
Vinals, M.1
Martinez-Gonzalez, J.2
Badimon, J.J.3
Badimon, L.4
-
22
-
-
10044258579
-
High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component
-
Tamama, K., H. Tomura, K. Sato, E. Malchinkhuu, A. Damirin, T. Kimura, A. Kuwabara, M. Murakami, and F. Okajima. 2005. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis. 178: 19-23.
-
(2005)
Atherosclerosis
, vol.178
, pp. 19-23
-
-
Tamama, K.1
Tomura, H.2
Sato, K.3
Malchinkhuu, E.4
Damirin, A.5
Kimura, T.6
Kuwabara, A.7
Murakami, M.8
Okajima, F.9
-
23
-
-
34250872735
-
Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells
-
Damirin, A., H. Tomura, M. Komachi, J. P. Liu, C. Mogi, M. Tobo, J. Q. Wang, T. Kimura, A. Kuwabara, Y. Yamazaki, et al. 2007. Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 292: H2513-H2522.
-
(2007)
Am. J. Physiol. Heart Circ. Physiol
, vol.292
-
-
Damirin, A.1
Tomura, H.2
Komachi, M.3
Liu, J.P.4
Mogi, C.5
Tobo, M.6
Wang, J.Q.7
Kimura, T.8
Kuwabara, A.9
Yamazaki, Y.10
-
24
-
-
52449129893
-
HDL-associated lysosphingolipids inhibit NAD(P)H oxidasedependent monocyte chemoattractant protein-1 production
-
Tolle, M., A. Pawlak, M. Schuchardt, A. Kawamura, U. J. Tietge, S. Lorkowski, P. Keul, G. Assmann, J. Chun, B. Levkau, et al. 2008. HDL-associated lysosphingolipids inhibit NAD(P)H oxidasedependent monocyte chemoattractant protein-1 production. Arterioscler. Thromb. Vasc. Biol. 28: 1542-1548.
-
(2008)
Arterioscler. Thromb. Vasc. Biol
, vol.28
, pp. 1542-1548
-
-
Tolle, M.1
Pawlak, A.2
Schuchardt, M.3
Kawamura, A.4
Tietge, U.J.5
Lorkowski, S.6
Keul, P.7
Assmann, G.8
Chun, J.9
Levkau, B.10
-
25
-
-
79957533056
-
Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation
-
Murphy, A. J., K. J. Woollard, A. Suhartoyo, R. A. Stirzaker, J. Shaw, D. Sviridov, and J. P. Chin-Dusting. 2011. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler. Thromb. Vasc. Biol. 31: 1333-1341.
-
(2011)
Arterioscler. Thromb. Vasc. Biol
, vol.31
, pp. 1333-1341
-
-
Murphy, A.J.1
Woollard, K.J.2
Suhartoyo, A.3
Stirzaker, R.A.4
Shaw, J.5
Sviridov, D.6
Chin-Dusting, J.P.7
-
26
-
-
55449105230
-
High-density lipoprotein reduces the human monocyte inflammatory response
-
Murphy, A. J., K. J. Woollard, A. Hoang, N. Mukhamedova, R. A. Stirzaker, S. P. McCormick, A. T. Remaley, D. Sviridov, and J. Chin-Dusting. 2008. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28: 2071-2077.
-
(2008)
Arterioscler. Thromb. Vasc. Biol
, vol.28
, pp. 2071-2077
-
-
Murphy, A.J.1
Woollard, K.J.2
Hoang, A.3
Mukhamedova, N.4
Stirzaker, R.A.5
McCormick, S.P.6
Remaley, A.T.7
Sviridov, D.8
Chin-Dusting, J.9
-
27
-
-
0031826009
-
Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo
-
Lerch, P. G., M. O. Spycher, and J. E. Doran. 1998. Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo. Thromb. Haemost. 80: 316-320.
-
(1998)
Thromb. Haemost
, vol.80
, pp. 316-320
-
-
Lerch, P.G.1
Spycher, M.O.2
Doran, J.E.3
-
28
-
-
73449107142
-
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux
-
Calkin, A. C., B. G. Drew, A. Ono, S. J. Duffy, M. V. Gordon, S. M. Schoenwaelder, D. Sviridov, M. E. Cooper, B. A. Kingwell, and S. P. Jackson. 2009. Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux. Circulation. 120: 2095-2104.
-
(2009)
Circulation
, vol.120
, pp. 2095-2104
-
-
Calkin, A.C.1
Drew, B.G.2
Ono, A.3
Duffy, S.J.4
Gordon, M.V.5
Schoenwaelder, S.M.6
Sviridov, D.7
Cooper, M.E.8
Kingwell, B.A.9
Jackson, S.P.10
-
29
-
-
78651379500
-
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
-
Khera, A. V., M. Cuchel, M. Llera-Moya, A. Rodrigues, M. F. Burke, K. Jafri, B. C. French, J. A. Phillips, M. L. Mucksavage, R. L. Wilensky, et al. 2011. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364: 127-135.
-
(2011)
N. Engl. J. Med
, vol.364
, pp. 127-135
-
-
Khera, A.V.1
Cuchel, M.2
Llera-Moya, M.3
Rodrigues, A.4
Burke, M.F.5
Jafri, K.6
French, B.C.7
Phillips, J.A.8
Mucksavage, M.L.9
Wilensky, R.L.10
-
30
-
-
84879113852
-
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
-
Epub ahead of print. March 21, doi:10.1161/ATVBAHA.113.301373
-
Li, X. M., W. H. Tang, M. K. Mosior, Y. Huang, Y. Wu, W. Matter, V. Gao, D. Schmitt, J. A. Didonato, E. A. Fisher, et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler. Thromb. Vasc. Biol. Epub ahead of print. March 21, 2013; doi:10.1161/ATVBAHA.113.301373.
-
(2013)
Arterioscler. Thromb. Vasc. Biol
-
-
Li, X.M.1
Tang, W.H.2
Mosior, M.K.3
Huang, Y.4
Wu, Y.5
Matter, W.6
Gao, V.7
Schmitt, D.8
Didonato, J.A.9
Fisher, E.A.10
-
31
-
-
10744224101
-
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
-
Ansell, B. J., M. Navab, S. Hama, N. Kamranpour, G. Fonarow, G. Hough, S. Rahmani, R. Mottahedeh, R. Dave, S. T. Reddy, et al. 2003. Inflammatory/ antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 108: 2751-2756.
-
(2003)
Circulation
, vol.108
, pp. 2751-2756
-
-
Ansell, B.J.1
Navab, M.2
Hama, S.3
Kamranpour, N.4
Fonarow, G.5
Hough, G.6
Rahmani, S.7
Mottahedeh, R.8
Dave, R.9
Reddy, S.T.10
-
32
-
-
79959919890
-
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
-
Besler, C., K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D. M. Shih, A. Chroni, K. Yonekawa, S. Stein, N. Schaefer, et al. 2011. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J. Clin. Invest. 121: 2693-2708.
-
(2011)
J. Clin. Invest
, vol.121
, pp. 2693-2708
-
-
Besler, C.1
Heinrich, K.2
Rohrer, L.3
Doerries, C.4
Riwanto, M.5
Shih, D.M.6
Chroni, A.7
Yonekawa, K.8
Stein, S.9
Schaefer, N.10
-
34
-
-
65449178091
-
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus
-
Drew, B. G., S. J. Duffy, M. F. Formosa, A. K. Natoli, D. C. Henstridge, S. A. Penfold, W. G. Thomas, N. Mukhamedova, B. de Courten, J. M. Forbes, et al. 2009. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 119: 2103-2111.
-
(2009)
Circulation
, vol.119
, pp. 2103-2111
-
-
Drew, B.G.1
Duffy, S.J.2
Formosa, M.F.3
Natoli, A.K.4
Henstridge, D.C.5
Penfold, S.A.6
Thomas, W.G.7
Mukhamedova, N.8
De Courten, B.9
Forbes, J.M.10
-
35
-
-
34547696757
-
Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism
-
Han, R., R. Lai, Q. Ding, Z. Wang, X. Luo, Y. Zhang, G. Cui, J. He, W. Liu, and Y. Chen. 2007. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia. 50: 1960-1968.
-
(2007)
Diabetologia
, vol.50
, pp. 1960-1968
-
-
Han, R.1
Lai, R.2
Ding, Q.3
Wang, Z.4
Luo, X.5
Zhang, Y.6
Cui, G.7
He, J.8
Liu, W.9
Chen, Y.10
-
36
-
-
77955170942
-
Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion
-
Fryirs, M. A., P. J. Barter, M. Appavoo, B. E. Tuch, F. Tabet, A. K. Heather, and K. A. Rye. 2010. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler. Thromb. Vasc. Biol. 30: 1642-1648.
-
(2010)
Arterioscler. Thromb. Vasc. Biol
, vol.30
, pp. 1642-1648
-
-
Fryirs, M.A.1
Barter, P.J.2
Appavoo, M.3
Tuch, B.E.4
Tabet, F.5
Heather, A.K.6
Rye, K.A.7
-
37
-
-
80051849862
-
High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells
-
Zhang, Q., Y. Zhang, H. Feng, R. Guo, L. Jin, R. Wan, L. Wang, C. Chen, and S. Li. 2011. High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells. PLoS ONE. 6: e23556.
-
(2011)
PLoS ONE
, vol.6
-
-
Zhang, Q.1
Zhang, Y.2
Feng, H.3
Guo, R.4
Jin, L.5
Wan, R.6
Wang, L.7
Chen, C.8
Li, S.9
-
38
-
-
79955666194
-
Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat
-
Ruan, X., Z. Li, Y. Zhang, L. Yang, Y. Pan, Z. Wang, G. S. Feng, and Y. Chen. 2011. Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat. J. Cell. Mol. Med. 15: 763-772.
-
(2011)
J. Cell. Mol. Med
, vol.15
, pp. 763-772
-
-
Ruan, X.1
Li, Z.2
Zhang, Y.3
Yang, L.4
Pan, Y.5
Wang, Z.6
Feng, G.S.7
Chen, Y.8
-
39
-
-
51449087136
-
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice
-
Peterson, S. J., G. Drummond, D. H. Kim, M. Li, A. L. Kruger, S. Ikehara, and N. G. Abraham. 2008. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J. Lipid Res. 49: 1658-1669.
-
(2008)
J. Lipid Res
, vol.49
, pp. 1658-1669
-
-
Peterson, S.J.1
Drummond, G.2
Kim, D.H.3
Li, M.4
Kruger, A.L.5
Ikehara, S.6
Abraham, N.G.7
-
40
-
-
0026779370
-
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus
-
Taskinen, M. R. 1992. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes. 41: 12-17.
-
(1992)
Diabetes
, vol.41
, pp. 12-17
-
-
Taskinen, M.R.1
-
41
-
-
0020077255
-
Abnormal composition of high density lipoproteins in non-insulin- dependent diabetics
-
Biesbroeck, R. C., J. J. Albers, P. W. Wahl, C. R. Weinberg, M. L. Bassett, and E. L. Bierman. 1982. Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes. 31: 126-131.
-
(1982)
Diabetes
, vol.31
, pp. 126-131
-
-
Biesbroeck, R.C.1
Albers, J.J.2
Wahl, P.W.3
Weinberg, C.R.4
Bassett, M.L.5
Bierman, E.L.6
-
42
-
-
33646531407
-
Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
-
Persegol, L., B. Verges, M. Foissac, P. Gambert, and L. Duvillard. 2006. Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia. 49: 1380-1386.
-
(2006)
Diabetologia
, vol.49
, pp. 1380-1386
-
-
Persegol, L.1
Verges, B.2
Foissac, M.3
Gambert, P.4
Duvillard, L.5
-
43
-
-
34848849569
-
HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
-
Persegol, L., M. Foissac, L. Lagrost, A. Athias, P. Gambert, B. Verges, and L. Duvillard. 2007. HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia. 50: 2384-2387.
-
(2007)
Diabetologia
, vol.50
, pp. 2384-2387
-
-
Persegol, L.1
Foissac, M.2
Lagrost, L.3
Athias, A.4
Gambert, P.5
Verges, B.6
Duvillard, L.7
-
44
-
-
34548151386
-
Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation
-
Persegol, L., B. Verges, P. Gambert, and L. Duvillard. 2007. Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation. J. Lipid Res. 48: 1396-1401.
-
(2007)
J. Lipid Res
, vol.48
, pp. 1396-1401
-
-
Persegol, L.1
Verges, B.2
Gambert, P.3
Duvillard, L.4
-
45
-
-
74549172922
-
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy
-
Sorrentino, S. A., C. Besler, L. Rohrer, M. Meyer, K. Heinrich, F. H. Bahlmann, M. Mueller, T. Horvath, C. Doerries, M. Heinemann, et al. 2010. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation. 121: 110-122.
-
(2010)
Circulation
, vol.121
, pp. 110-122
-
-
Sorrentino, S.A.1
Besler, C.2
Rohrer, L.3
Meyer, M.4
Heinrich, K.5
Bahlmann, F.H.6
Mueller, M.7
Horvath, T.8
Doerries, C.9
Heinemann, M.10
-
46
-
-
0031455505
-
HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL
-
Suc, I., I. Escargueil-Blanc, M. Troly, R. Salvayre, and A. Negre- Salvayre. 1997. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17: 2158-2166.
-
(1997)
Arterioscler. Thromb. Vasc. Biol
, vol.17
, pp. 2158-2166
-
-
Suc, I.1
Escargueil-Blanc, I.2
Troly, M.3
Salvayre, R.4
Negre- Salvayre, A.5
-
47
-
-
0034674349
-
High-density lipoproteins protect endothelial cells from tumor necrosis factoralpha- induced apoptosis
-
Sugano, M., K. Tsuchida, and N. Makino. 2000. High-density lipoproteins protect endothelial cells from tumor necrosis factoralpha- induced apoptosis. Biochem. Biophys. Res. Commun. 272: 872-876.
-
(2000)
Biochem. Biophys. Res. Commun
, vol.272
, pp. 872-876
-
-
Sugano, M.1
Tsuchida, K.2
Makino, N.3
-
48
-
-
0035860805
-
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids
-
Nofer, J. R., B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann. 2001. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J. Biol. Chem. 276: 34480-34485.
-
(2001)
J. Biol. Chem
, vol.276
, pp. 34480-34485
-
-
Nofer, J.R.1
Levkau, B.2
Wolinska, I.3
Junker, R.4
Fobker, M.5
Von Eckardstein, A.6
Seedorf, U.7
Assmann, G.8
-
49
-
-
0038785578
-
High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors
-
Kimura, T., K. Sato, E. Malchinkhuu, H. Tomura, K. Tamama, A. Kuwabara, M. Murakami, and F. Okajima. 2003. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol. 23: 1283-1288.
-
(2003)
Arterioscler. Thromb. Vasc. Biol
, vol.23
, pp. 1283-1288
-
-
Kimura, T.1
Sato, K.2
Malchinkhuu, E.3
Tomura, H.4
Tamama, K.5
Kuwabara, A.6
Murakami, M.7
Okajima, F.8
-
50
-
-
20544474751
-
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes
-
Kruger, A. L., S. Peterson, S. Turkseven, P. M. Kaminski, F. F. Zhang, S. Quan, M. S. Wolin, and N. G. Abraham. 2005. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation. 111: 3126-3134.
-
(2005)
Circulation
, vol.111
, pp. 3126-3134
-
-
Kruger, A.L.1
Peterson, S.2
Turkseven, S.3
Kaminski, P.M.4
Zhang, F.F.5
Quan, S.6
Wolin, M.S.7
Abraham, N.G.8
-
51
-
-
0018830726
-
Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells
-
Tauber, J. P., J. Cheng, and D. Gospodarowicz. 1980. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J. Clin. Invest. 66: 696-708.
-
(1980)
J. Clin. Invest
, vol.66
, pp. 696-708
-
-
Tauber, J.P.1
Cheng, J.2
Gospodarowicz, D.3
-
52
-
-
0019815722
-
High density lipoproteins and the growth of vascular endothelial cells in serum-free medium
-
Tauber, J. P., J. Cheng, S. Massoglia, and D. Gospodarowicz. 1981. High density lipoproteins and the growth of vascular endothelial cells in serum-free medium. In Vitro. 17: 519-530.
-
(1981)
Vitro
, vol.17
, pp. 519-530
-
-
Tauber, J.P.1
Cheng, J.2
Massoglia, S.3
Gospodarowicz, D.4
-
53
-
-
0029994882
-
Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells
-
Tamagaki, T., S. Sawada, H. Imamura, Y. Tada, S. Yamasaki, A. Toratani, T. Sato, S. Komatsu, N. Akamatsu, M. Yamagami, et al. 1996. Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells. Atherosclerosis. 123: 73-82.
-
(1996)
Atherosclerosis
, vol.123
, pp. 73-82
-
-
Tamagaki, T.1
Sawada, S.2
Imamura, H.3
Tada, Y.4
Yamasaki, S.5
Toratani, A.6
Sato, T.7
Komatsu, S.8
Akamatsu, N.9
Yamagami, M.10
-
54
-
-
0028234578
-
High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor
-
Murugesan, G., G. Sa, and P. L. Fox. 1994. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ. Res. 74: 1149-1156.
-
(1994)
Circ. Res
, vol.74
, pp. 1149-1156
-
-
Murugesan, G.1
Sa, G.2
Fox, P.L.3
-
55
-
-
0038137626
-
High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells
-
Miura, S., M. Fujino, Y. Matsuo, A. Kawamura, H. Tanigawa, H. Nishikawa, and K. Saku. 2003. High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: 802-808.
-
(2003)
Arterioscler. Thromb. Vasc. Biol
, vol.23
, pp. 802-808
-
-
Miura, S.1
Fujino, M.2
Matsuo, Y.3
Kawamura, A.4
Tanigawa, H.5
Nishikawa, H.6
Saku, K.7
-
56
-
-
33644844393
-
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type i
-
Seetharam, D., C. Mineo, A. K. Gormley, L. L. Gibson, W. Vongpatanasin, K. L. Chambliss, L. D. Hahner, M. L. Cummings, R. L. Kitchens, Y. L. Marcel, et al. 2006. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 98: 63-72.
-
(2006)
Circ. Res
, vol.98
, pp. 63-72
-
-
Seetharam, D.1
Mineo, C.2
Gormley, A.K.3
Gibson, L.L.4
Vongpatanasin, W.5
Chambliss, K.L.6
Hahner, L.D.7
Cummings, M.L.8
Kitchens, R.L.9
Marcel, Y.L.10
-
57
-
-
60249097216
-
Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer
-
Feng, Y., M. Van Eck, E. Van Craeyveld, F. Jacobs, V. Carlier, S. Van Linthout, M. Erdel, M. Tjwa, and B. De Geest. 2009. Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood. 113: 755-764.
-
(2009)
Blood
, vol.113
, pp. 755-764
-
-
Feng, Y.1
Van Eck, M.2
Van Craeyveld, E.3
Jacobs, F.4
Carlier, V.5
Van Linthout, S.6
Erdel, M.7
Tjwa, M.8
De Geest, B.9
-
58
-
-
77957164540
-
Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway
-
Zhang, Q., H. Yin, P. Liu, H. Zhang, and M. She. 2010. Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway. Exp. Biol. Med. (Maywood). 235: 1082-1092.
-
(2010)
Exp. Biol. Med. (Maywood)
, vol.235
, pp. 1082-1092
-
-
Zhang, Q.1
Yin, H.2
Liu, P.3
Zhang, H.4
She, M.5
-
59
-
-
0028865357
-
High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
-
Cockerill, G. W., K. A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15: 1987-1994.
-
(1995)
Arterioscler. Thromb. Vasc. Biol
, vol.15
, pp. 1987-1994
-
-
Cockerill, G.W.1
Rye, K.A.2
Gamble, J.R.3
Vadas, M.A.4
Barter, P.J.5
-
60
-
-
33846016241
-
Role of scavenger receptor class B type i and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells
-
Kimura, T., H. Tomura, C. Mogi, A. Kuwabara, A. Damirin, T. Ishizuka, A. Sekiguchi, M. Ishiwara, D. S. Im, K. Sato, et al. 2006. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J. Biol. Chem. 281: 37457-37467.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 37457-37467
-
-
Kimura, T.1
Tomura, H.2
Mogi, C.3
Kuwabara, A.4
Damirin, A.5
Ishizuka, T.6
Sekiguchi, A.7
Ishiwara, M.8
Im, D.S.9
Sato, K.10
-
61
-
-
84872871320
-
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3beta-hydroxysteroid-Delta24 reductase expression and inducing heme oxygenase-1
-
Wu, B. J., K. Chen, S. Shrestha, K. L. Ong, P. J. Barter, and K. A. Rye. 2013. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3beta-hydroxysteroid-Delta24 reductase expression and inducing heme oxygenase-1. Circ. Res. 112: 278-288.
-
(2013)
Circ. Res
, vol.112
, pp. 278-288
-
-
Wu, B.J.1
Chen, K.2
Shrestha, S.3
Ong, K.L.4
Barter, P.J.5
Rye, K.A.6
-
62
-
-
77951167843
-
Mechanism and role of high density lipoprotein-induced activation of AMPactivated protein kinase in endothelial cells
-
Kimura, T., H. Tomura, K. Sato, M. Ito, I. Matsuoka, D. S. Im, A. Kuwabara, C. Mogi, H. Itoh, H. Kurose, et al. 2010. Mechanism and role of high density lipoprotein-induced activation of AMPactivated protein kinase in endothelial cells. J. Biol. Chem. 285: 4387-4397.
-
(2010)
J. Biol. Chem
, vol.285
, pp. 4387-4397
-
-
Kimura, T.1
Tomura, H.2
Sato, K.3
Ito, M.4
Matsuoka, I.5
Im, D.S.6
Kuwabara, A.7
Mogi, C.8
Itoh, H.9
Kurose, H.10
-
63
-
-
84859133300
-
Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts
-
Cheng, A. M., P. Handa, S. Tateya, J. Schwartz, C. Tang, P. Mitra, J. F. Oram, A. Chait, and F. Kim. 2012. Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts. PLoS ONE. 7: e33917.
-
(2012)
PLoS ONE
, vol.7
-
-
Cheng, A.M.1
Handa, P.2
Tateya, S.3
Schwartz, J.4
Tang, C.5
Mitra, P.6
Oram, J.F.7
Chait, A.8
Kim, F.9
-
64
-
-
0034927750
-
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
-
Yuhanna, I. S., Y. Zhu, B. E. Cox, L. D. Hahner, S. Osborne- Lawrence, P. Lu, Y. L. Marcel, R. G. Anderson, M. E. Mendelsohn, H. H. Hobbs, et al. 2001. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7: 853-857.
-
(2001)
Nat. Med
, vol.7
, pp. 853-857
-
-
Yuhanna, I.S.1
Zhu, Y.2
Cox, B.E.3
Hahner, L.D.4
Osborne- Lawrence, S.5
Lu, P.6
Marcel, Y.L.7
Anderson, R.G.8
Mendelsohn, M.E.9
Hobbs, H.H.10
-
65
-
-
2342476366
-
High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation
-
Drew, B. G., N. H. Fidge, G. Gallon-Beaumier, B. E. Kemp, and B. A. Kingwell. 2004. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc. Natl. Acad. Sci. USA. 101: 6999-7004.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 6999-7004
-
-
Drew, B.G.1
Fidge, N.H.2
Gallon-Beaumier, G.3
Kemp, B.E.4
Kingwell, B.A.5
-
66
-
-
0029664995
-
Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae
-
Shaul, P. W., E. J. Smart, L. J. Robinson, Z. German, I. S. Yuhanna, Y. Ying, R. G. Anderson, and T. Michel. 1996. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271: 6518-6522.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 6518-6522
-
-
Shaul, P.W.1
Smart, E.J.2
Robinson, L.J.3
German, Z.4
Yuhanna, I.S.5
Ying, Y.6
Anderson, R.G.7
Michel, T.8
-
67
-
-
0038322055
-
High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases
-
Mineo, C., I. S. Yuhanna, M. J. Quon, and P. W. Shaul. 2003. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J. Biol. Chem. 278: 9142-9149.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 9142-9149
-
-
Mineo, C.1
Yuhanna, I.S.2
Quon, M.J.3
Shaul, P.W.4
-
68
-
-
20344370015
-
High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells
-
Norata, G. D., E. Callegari, M. Marchesi, G. Chiesa, P. Eriksson, and A. L. Catapano. 2005. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation. 111: 2805-2811.
-
(2005)
Circulation
, vol.111
, pp. 2805-2811
-
-
Norata, G.D.1
Callegari, E.2
Marchesi, M.3
Chiesa, G.4
Eriksson, P.5
Catapano, A.L.6
-
69
-
-
0032921437
-
High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells
-
Honda, H. M., B. K. Wakamatsu, J. I. Goldhaber, J. A. Berliner, M. Navab, and J. N. Weiss. 1999. High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells. Atherosclerosis. 143: 299-306.
-
(1999)
Atherosclerosis
, vol.143
, pp. 299-306
-
-
Honda, H.M.1
Wakamatsu, B.K.2
Goldhaber, J.I.3
Berliner, J.A.4
Navab, M.5
Weiss, J.N.6
-
70
-
-
11144356028
-
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
-
Nofer, J. R., M. van der Giet, M. Tolle, I. Wolinska, L. K. von Wnuck, H. A. Baba, U. J. Tietge, A. Godecke, I. Ishii, B. Kleuser, et al. 2004. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J. Clin. Invest. 113: 569-581.
-
(2004)
J. Clin. Invest
, vol.113
, pp. 569-581
-
-
Nofer, J.R.1
Giet Der M.Van2
Tolle, M.3
Wolinska, I.4
Von Wnuck, L.K.5
Baba, H.A.6
Tietge, U.J.7
Godecke, A.8
Ishii, I.9
Kleuser, B.10
-
71
-
-
0037192815
-
High density lipoprotein binding to scavenger receptor, class B, type i activates endothelial nitric-oxide synthase in a ceramide-dependent manner
-
Li, X. A., W. B. Titlow, B. A. Jackson, N. Giltiay, M. Nikolova- Karakashian, A. Uittenbogaard, and E. J. Smart. 2002. High density lipoprotein binding to scavenger receptor, class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J. Biol. Chem. 277: 11058-11063.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 11058-11063
-
-
Li, X.A.1
Titlow, W.B.2
Jackson, B.A.3
Giltiay, N.4
Nikolova-Karakashian, M.5
Uittenbogaard, A.6
Smart, E.J.7
-
72
-
-
0037971528
-
High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life
-
Ramet, M. E., M. Ramet, Q. Lu, M. Nickerson, M. J. Savolainen, A. Malzone, and R. H. Karas. 2003. High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J. Am. Coll. Cardiol. 41: 2288-2297.
-
(2003)
J. Am. Coll. Cardiol
, vol.41
, pp. 2288-2297
-
-
Ramet, M.E.1
Ramet, M.2
Lu, Q.3
Nickerson, M.4
Savolainen, M.J.5
Malzone, A.6
Karas, R.H.7
-
73
-
-
34247339395
-
High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis
-
Noor, R., U. Shuaib, C. X. Wang, K. Todd, U. Ghani, B. Schwindt, and A. Shuaib. 2007. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis. 192: 92-99.
-
(2007)
Atherosclerosis
, vol.192
, pp. 92-99
-
-
Noor, R.1
Shuaib, U.2
Wang, C.X.3
Todd, K.4
Ghani, U.5
Schwindt, B.6
Shuaib, A.7
-
74
-
-
77955601265
-
HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production
-
Carpintero, R., L. Gruaz, K. J. Brandt, A. Scanu, D. Faille, V. Combes, G. E. Grau, and D. Burger. 2010. HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production. PLoS ONE. 5: e11869.
-
(2010)
PLoS ONE
, vol.5
-
-
Carpintero, R.1
Gruaz, L.2
Brandt, K.J.3
Scanu, A.4
Faille, D.5
Combes, V.6
Grau, G.E.7
Burger, D.8
-
75
-
-
27744526914
-
Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation
-
Kim, K. D., H. Y. Lim, H. G. Lee, D. Y. Yoon, Y. K. Choe, I. Choi, S. G. Paik, Y. S. Kim, Y. Yang, and J. S. Lim. 2005. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem. Biophys. Res. Commun. 338: 1126-1136.
-
(2005)
Biochem. Biophys. Res. Commun
, vol.338
, pp. 1126-1136
-
-
Kim, K.D.1
Lim, H.Y.2
Lee, H.G.3
Yoon, D.Y.4
Choe, Y.K.5
Choi, I.6
Paik, S.G.7
Kim, Y.S.8
Yang, Y.9
Lim, J.S.10
-
76
-
-
70450255118
-
The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor
-
Tang, C., Y. Liu, P. S. Kessler, A. M. Vaughan, and J. F. Oram. 2009. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 284: 32336-32343.
-
(2009)
J. Biol. Chem
, vol.284
, pp. 32336-32343
-
-
Tang, C.1
Liu, Y.2
Kessler, P.S.3
Vaughan, A.M.4
Oram, J.F.5
-
77
-
-
79955620739
-
Lipidfree apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages
-
Tabet, F., G. Lambert, L. F. Cuesta Torres, L. Hou, I. Sotirchos, R. M. Touyz, A. J. Jenkins, P. J. Barter, and K. A. Rye. 2011. Lipidfree apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages. Arterioscler. Thromb. Vasc. Biol. 31: 1192-1200.
-
(2011)
Arterioscler. Thromb. Vasc. Biol
, vol.31
, pp. 1192-1200
-
-
Tabet, F.1
Lambert, G.2
Cuesta Torres, L.F.3
Hou, L.4
Sotirchos, I.5
Touyz, R.M.6
Jenkins, A.J.7
Barter, P.J.8
Rye, K.A.9
-
78
-
-
77954039619
-
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation
-
Yvan-Charvet, L., T. Pagler, E. L. Gautier, S. Avagyan, R. L. Siry, S. Han, C. L. Welch, N. Wang, G. J. Randolph, H. W. Snoeck, et al. 2010. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 328: 1689-1693.
-
(2010)
Science
, vol.328
, pp. 1689-1693
-
-
Yvan-Charvet, L.1
Pagler, T.2
Gautier, E.L.3
Avagyan, S.4
Siry, R.L.5
Han, S.6
Welch, C.L.7
Wang, N.8
Randolph, G.J.9
Snoeck, H.W.10
-
79
-
-
0032967387
-
Inhibition of arterial thrombus formation by ApoA1 Milano
-
Li, D., S. Weng, B. Yang, D. S. Zander, T. Saldeen, W. W. Nichols, S. Khan, and J. L. Mehta. 1999. Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler. Thromb. Vasc. Biol. 19: 378-383.
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 378-383
-
-
Li, D.1
Weng, S.2
Yang, B.3
Zander, D.S.4
Saldeen, T.5
Nichols, W.W.6
Khan, S.7
Mehta, J.L.8
-
80
-
-
0031045302
-
Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia
-
Pajkrt, D., P. G. Lerch, T. van der Poll, M. Levi, M. Illi, J. E. Doran, B. Arnet, A. van den Ende, J. W. Cate, and S. J. van Deventer. 1997. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb. Haemost. 77: 303-307.
-
(1997)
Thromb. Haemost
, vol.77
, pp. 303-307
-
-
Pajkrt, D.1
Lerch, P.G.2
Poll Der T.Van3
Levi, M.4
Illi, M.5
Doran, J.E.6
Arnet, B.7
Ende Den A.Van8
Cate, J.W.9
Van Deventer, S.J.10
-
81
-
-
0020319988
-
Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins
-
Fleisher, L. N., A. R. Tall, L. D. Witte, R. W. Miller, and P. J. Cannon. 1982. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J. Biol. Chem. 257: 6653-6655.
-
(1982)
J. Biol. Chem
, vol.257
, pp. 6653-6655
-
-
Fleisher, L.N.1
Tall, A.R.2
Witte, L.D.3
Miller, R.W.4
Cannon, P.J.5
-
82
-
-
0030061898
-
High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells
-
Sugatani, J., M. Miwa, Y. Komiyama, and S. Ito. 1996. High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells. J. Lipid Mediat. Cell Signal. 13: 73-88.
-
(1996)
J. Lipid Mediat. Cell Signal
, vol.13
, pp. 73-88
-
-
Sugatani, J.1
Miwa, M.2
Komiyama, Y.3
Ito, S.4
-
83
-
-
0032532418
-
The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion
-
Oravec, S., K. Demuth, I. Myara, and A. Hornych. 1998. The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion. Thromb. Res. 92: 65-71.
-
(1998)
Thromb. Res
, vol.92
, pp. 65-71
-
-
Oravec, S.1
Demuth, K.2
Myara, I.3
Hornych, A.4
-
84
-
-
1842863230
-
Reconstituted highdensity lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase
-
Viswambharan, H., X. F. Ming, S. Zhu, A. Hubsch, P. Lerch, G. Vergeres, S. Rusconi, and Z. Yang. 2004. Reconstituted highdensity lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ. Res. 94: 918-925.
-
(2004)
Circ. Res
, vol.94
, pp. 918-925
-
-
Viswambharan, H.1
Ming, X.F.2
Zhu, S.3
Hubsch, A.4
Lerch, P.5
Vergeres, G.6
Rusconi, S.7
Yang, Z.8
-
85
-
-
33746613292
-
Platelet activation by low density lipoprotein and high density lipoprotein
-
Korporaal, S. J., and J. W. Akkerman. 2006. Platelet activation by low density lipoprotein and high density lipoprotein. Pathophysiol. Haemost. Thromb. 35: 270-280.
-
(2006)
Pathophysiol. Haemost. Thromb
, vol.35
, pp. 270-280
-
-
Korporaal, S.J.1
Akkerman, J.W.2
-
86
-
-
77953865873
-
High-density lipoproteins, platelets and the pathogenesis of atherosclerosis
-
Nofer, J. R., M. F. Brodde, and B. E. Kehrel. 2010. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin. Exp. Pharmacol. Physiol. 37: 726-735.
-
(2010)
Clin. Exp. Pharmacol. Physiol
, vol.37
, pp. 726-735
-
-
Nofer, J.R.1
Brodde, M.F.2
Kehrel, B.E.3
-
87
-
-
0036252997
-
Platelet activation by the apoB/E receptor-binding domain of LDL
-
Relou, A. M., G. Gorter, H. J. van Rijn, and J. W. Akkerman. 2002. Platelet activation by the apoB/E receptor-binding domain of LDL. Thromb. Haemost. 87: 880-887.
-
(2002)
Thromb. Haemost
, vol.87
, pp. 880-887
-
-
Relou, A.M.1
Gorter, G.2
Van Rijn, H.J.3
Akkerman, J.W.4
-
88
-
-
0023832890
-
Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle
-
Knorr, M., R. Locher, E. Vogt, W. Vetter, L. H. Block, F. Ferracin, H. Lefkovits, and A. Pletscher. 1988. Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle. Eur. J. Biochem. 172: 753-759.
-
(1988)
Eur. J. Biochem
, vol.172
, pp. 753-759
-
-
Knorr, M.1
Locher, R.2
Vogt, E.3
Vetter, W.4
Block, L.H.5
Ferracin, F.6
Lefkovits, H.7
Pletscher, A.8
-
89
-
-
79960644582
-
HDL scavenger receptor class B type i and platelet function
-
Nofer, J. R., and E. M. Van. 2011. HDL scavenger receptor class B type I and platelet function. Curr. Opin. Lipidol. 22: 277-282.
-
(2011)
Curr. Opin. Lipidol
, vol.22
, pp. 277-282
-
-
Nofer, J.R.1
Van, E.M.2
-
90
-
-
33646402083
-
Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation
-
Inokuma, K., Y. Okamatsu-Ogura, A. Omachi, Y. Matsushita, K. Kimura, H. Yamashita, and M. Saito. 2006. Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation. Am. J. Physiol. Endocrinol. Metab. 290: E1014-E1021.
-
(2006)
Am. J. Physiol. Endocrinol. Metab
, vol.290
-
-
Inokuma, K.1
Okamatsu-Ogura, Y.2
Omachi, A.3
Matsushita, Y.4
Kimura, K.5
Yamashita, H.6
Saito, M.7
-
91
-
-
77952474019
-
Impact of HDL on adipose tissue metabolism and adiponectin expression
-
Van Linthout, S., A. Foryst-Ludwig, F. Spillmann, J. Peng, Y. Feng, M. Meloni, E. Van Craeyveld, U. Kintscher, H. P. Schultheiss, B. De Geest, et al. 2010. Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis. 210: 438-444.
-
(2010)
Atherosclerosis
, vol.210
, pp. 438-444
-
-
Van Linthout, S.1
Foryst-Ludwig, A.2
Spillmann, F.3
Peng, J.4
Feng, Y.5
Meloni, M.6
Van Craeyveld, E.7
Kintscher, U.8
Schultheiss, H.P.9
De Geest, B.10
-
92
-
-
84879809218
-
Apolipoprotein A-I and HDL have antiinflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette (ABC) A-1 ABCG-1 and scavenger receptor B-1(SRB-1)
-
March 15, doi:10.1161/CIRCRESAHA.111.300581
-
Umemoto, T., C. Y. Han, P. Mitra, M. M. Averill, C. Tang, L. Goodspeed, M. A. Omer, S. Subramanian, S. Wang, L. J. Den Hartigh, et al. 2013. Apolipoprotein A-I and HDL have antiinflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette (ABC) A-1, ABCG-1 and scavenger receptor B-1(SRB-1). Circ. Res. Epub ahead of print. March 15, 2013; doi:10.1161/CIRCRESAHA.111.300581.
-
(2013)
Circ. Res. Epub Ahead of Print
, vol.2013
-
-
Umemoto, T.1
Han, C.Y.2
Mitra, P.3
Averill, M.M.4
Tang, C.5
Goodspeed, L.6
Omer, M.A.7
Subramanian, S.8
Wang, S.9
Den Hartigh, L.J.10
-
93
-
-
84876802423
-
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
-
Dalla-Riva, J., K. G. Stenkula, J. Petrlova, and J. O. Lagerstedt. 2013. Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle. J. Lipid Res. 54: 1275-1282.
-
(2013)
J. Lipid Res
, vol.54
, pp. 1275-1282
-
-
Dalla-Riva, J.1
Stenkula, K.G.2
Petrlova, J.3
Lagerstedt, J.O.4
-
94
-
-
0038381515
-
Insulin-secreting beta-cell dysfunction induced by human lipoproteins
-
Roehrich, M. E., V. Mooser, V. Lenain, J. Herz, J. Nimpf, S. Azhar, M. Bideau, A. Capponi, P. Nicod, J. A. Haefliger, et al. 2003. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J. Biol. Chem. 278: 18368-18375.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 18368-18375
-
-
Roehrich, M.E.1
Mooser, V.2
Lenain, V.3
Herz, J.4
Nimpf, J.5
Azhar, S.6
Bideau, M.7
Capponi, A.8
Nicod, P.9
Haefliger, J.A.10
-
95
-
-
0037930797
-
High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras
-
Grewal, T., I. de Diego, M. F. Kirchhoff, F. Tebar, J. Heeren, F. Rinninger, and C. Enrich. 2003. High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras. J. Biol. Chem. 278: 16478-16481.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 16478-16481
-
-
Grewal, T.1
De Diego, I.2
Kirchhoff, M.F.3
Tebar, F.4
Heeren, J.5
Rinninger, F.6
Enrich, C.7
-
96
-
-
0036189524
-
HDL and arteriosclerosis: Beyond reverse cholesterol transport
-
Nofer, J. R., B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. von Eckardstein. 2002. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161: 1-16.
-
(2002)
Atherosclerosis
, vol.161
, pp. 1-16
-
-
Nofer, J.R.1
Kehrel, B.2
Fobker, M.3
Levkau, B.4
Assmann, G.5
Von Eckardstein, A.6
-
97
-
-
20144389763
-
Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling
-
Assanasen, C., C. Mineo, D. Seetharam, I. S. Yuhanna, Y. L. Marcel, M. A. Connelly, D. L. Williams, M. Llera-Moya, P. W. Shaul, and D. L. Silver. 2005. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J. Clin. Invest. 115: 969-977.
-
(2005)
J. Clin. Invest
, vol.115
, pp. 969-977
-
-
Assanasen, C.1
Mineo, C.2
Seetharam, D.3
Yuhanna, I.S.4
Marcel, Y.L.5
Connelly, M.A.6
Williams, D.L.7
Llera-Moya, M.8
Shaul, P.W.9
Silver, D.L.10
-
98
-
-
34548386258
-
Direct effect of cholesterol on insulin secretion: A novel mechanism for pancreatic beta-cell dysfunction
-
Hao, M., W. S. Head, S. C. Gunawardana, A. H. Hasty, and D. W. Piston. 2007. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes. 56: 2328-2338.
-
(2007)
Diabetes
, vol.56
, pp. 2328-2338
-
-
Hao, M.1
Head, W.S.2
Gunawardana, S.C.3
Hasty, A.H.4
Piston, D.W.5
-
99
-
-
1642300417
-
Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter
-
Haidar, B., M. Denis, M. Marcil, L. Krimbou, and J. Genest, Jr. 2004. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J. Biol. Chem. 279: 9963-9969.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 9963-9969
-
-
Haidar, B.1
Denis, M.2
Marcil, M.3
Krimbou, L.4
Genest Jr., J.5
-
100
-
-
0033613166
-
Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calciumdependent pathway
-
Takahashi, Y., and J. D. Smith. 1999. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calciumdependent pathway. Proc. Natl. Acad. Sci. USA. 96: 11358-11363.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 11358-11363
-
-
Takahashi, Y.1
Smith, J.D.2
-
101
-
-
0347918856
-
Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly
-
Yamauchi, Y., M. Hayashi, S. Abe-Dohmae, and S. Yokoyama. 2003. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J. Biol. Chem. 278: 47890-47897.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 47890-47897
-
-
Yamauchi, Y.1
Hayashi, M.2
Abe-Dohmae, S.3
Yokoyama, S.4
-
102
-
-
79953221107
-
Transcriptional regulation of ATP-binding cassette transporter A1 expression by a novel signaling pathway
-
Chen, X., Y. Zhao, Z. Guo, L. Zhou, E. U. Okoro, and H. Yang. 2011. Transcriptional regulation of ATP-binding cassette transporter A1 expression by a novel signaling pathway. J. Biol. Chem. 286: 8917-8923.
-
(2011)
J. Biol. Chem
, vol.286
, pp. 8917-8923
-
-
Chen, X.1
Zhao, Y.2
Guo, Z.3
Zhou, L.4
Okoro, E.U.5
Yang, H.6
-
103
-
-
35348854570
-
Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids
-
Thymiakou, E., V. I. Zannis, and D. Kardassis. 2007. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids. Biochemistry. 46: 11473-11483.
-
(2007)
Biochemistry
, vol.46
, pp. 11473-11483
-
-
Thymiakou, E.1
Zannis, V.I.2
Kardassis, D.3
-
104
-
-
1542320076
-
Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol
-
Tang, C., A. M. Vaughan, and J. F. Oram. 2004. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279: 7622-7628.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 7622-7628
-
-
Tang, C.1
Vaughan, A.M.2
Oram, J.F.3
-
105
-
-
33645520691
-
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter
-
Nofer, J. R., A. T. Remaley, R. Feuerborn, I. Wolinnska, T. Engel, A. von Eckardstein, and G. Assmann. 2006. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J. Lipid Res. 47: 794-803.
-
(2006)
J. Lipid Res
, vol.47
, pp. 794-803
-
-
Nofer, J.R.1
Remaley, A.T.2
Feuerborn, R.3
Wolinnska, I.4
Engel, T.5
Von Eckardstein, A.6
Assmann, G.7
-
106
-
-
0347362786
-
Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux
-
Nofer, J. R., R. Feuerborn, B. Levkau, A. Sokoll, U. Seedorf, and G. Assmann. 2003. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J. Biol. Chem. 278: 53055-53062.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 53055-53062
-
-
Nofer, J.R.1
Feuerborn, R.2
Levkau, B.3
Sokoll, A.4
Seedorf, U.5
Assmann, G.6
-
107
-
-
0034634502
-
Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - The small G protein may play a role in cholesterol efflux
-
Hirano, K., F. Matsuura, K. Tsukamoto, Z. Zhang, A. Matsuyama, K. Takaishi, R. Komuro, T. Suehiro, S. Yamashita, Y. Takai, et al. 2000. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux. FEBS Lett. 484: 275-279.
-
(2000)
FEBS Lett
, vol.484
, pp. 275-279
-
-
Hirano, K.1
Matsuura, F.2
Tsukamoto, K.3
Zhang, Z.4
Matsuyama, A.5
Takaishi, K.6
Komuro, R.7
Suehiro, T.8
Yamashita, S.9
Takai, Y.10
-
108
-
-
77952338862
-
Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation
-
Okuhira, K., M. L. Fitzgerald, N. Tamehiro, N. Ohoka, K. Suzuki, J. Sawada, M. Naito, and T. Nishimaki-Mogami. 2010. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation. J. Biol. Chem. 285: 16369-16377.
-
(2010)
J. Biol. Chem
, vol.285
, pp. 16369-16377
-
-
Okuhira, K.1
Fitzgerald, M.L.2
Tamehiro, N.3
Ohoka, N.4
Suzuki, K.5
Sawada, J.6
Naito, M.7
Nishimaki-Mogami, T.8
-
109
-
-
18644378203
-
Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux
-
See, R. H., R. A. Caday-Malcolm, R. R. Singaraja, S. Zhou, A. Silverston, M. T. Huber, J. Moran, E. R. James, R. Janoo, J. M. Savill, et al. 2002. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J. Biol. Chem. 277: 41835-41842.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 41835-41842
-
-
See, R.H.1
Caday-Malcolm, R.A.2
Singaraja, R.R.3
Zhou, S.4
Silverston, A.5
Huber, M.T.6
Moran, J.7
James, E.R.8
Janoo, R.9
Savill, J.M.10
-
110
-
-
77953933427
-
Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation
-
Iwamoto, N., R. Lu, N. Tanaka, S. Abe-Dohmae, and S. Yokoyama. 2010. Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation. Arterioscler. Thromb. Vasc. Biol. 30: 1446-1452.
-
(2010)
Arterioscler. Thromb. Vasc. Biol
, vol.30
, pp. 1446-1452
-
-
Iwamoto, N.1
Lu, R.2
Tanaka, N.3
Abe-Dohmae, S.4
Yokoyama, S.5
-
111
-
-
77949780930
-
Adipocyte modulation of high-density lipoprotein cholesterol
-
Zhang, Y., F. C. McGillicuddy, C. C. Hinkle, S. O'Neill, J. M. Glick, G. H. Rothblat, and M. P. Reilly. 2010. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation. 121: 1347-1355.
-
(2010)
Circulation
, vol.121
, pp. 1347-1355
-
-
Zhang, Y.1
McGillicuddy, F.C.2
Hinkle, C.C.3
O'neill, S.4
Glick, J.M.5
Rothblat, G.H.6
Reilly, M.P.7
-
112
-
-
67049143906
-
Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI
-
Kocher, O., and M. Krieger. 2009. Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr. Opin. Lipidol. 20: 236-241.
-
(2009)
Curr. Opin. Lipidol
, vol.20
, pp. 236-241
-
-
Kocher, O.1
Krieger, M.2
-
113
-
-
41949142738
-
The scavenger receptor class B type i adaptor protein PDZK1 maintains endothelial monolayer integrity
-
Zhu, W., S. Saddar, D. Seetharam, K. L. Chambliss, C. Longoria, D. L. Silver, I. S. Yuhanna, P. W. Shaul, and C. Mineo. 2008. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ. Res. 102: 480-487.
-
(2008)
Circ. Res
, vol.102
, pp. 480-487
-
-
Zhu, W.1
Saddar, S.2
Seetharam, D.3
Chambliss, K.L.4
Longoria, C.5
Silver, D.L.6
Yuhanna, I.S.7
Shaul, P.W.8
Mineo, C.9
-
114
-
-
85027917078
-
Scavenger receptor class B type i is a plasma membrane cholesterol sensor
-
Saddar, S., V. Carriere, W. R. Lee, K. Tanigaki, I. S. Yuhanna, S. Parathath, E. Morel, M. Warrier, J. K. Sawyer, R. D. Gerard, et al. 2013. Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ. Res. 112: 140-151.
-
(2013)
Circ. Res
, vol.112
, pp. 140-151
-
-
Saddar, S.1
Carriere, V.2
Lee, W.R.3
Tanigaki, K.4
Yuhanna, I.S.5
Parathath, S.6
Morel, E.7
Warrier, M.8
Sawyer, J.K.9
Gerard, R.D.10
-
115
-
-
79957882578
-
Metabolic and functional relevance of HDL subspecies
-
Asztalos, B. F., M. Tani, and E. J. Schaefer. 2011. Metabolic and functional relevance of HDL subspecies. Curr. Opin. Lipidol. 22: 176-185.
-
(2011)
Curr. Opin. Lipidol
, vol.22
, pp. 176-185
-
-
Asztalos, B.F.1
Tani, M.2
Schaefer, E.J.3
|